ATE301664T1 - Boronsäurehaltige reagenzien und oligonukleotide - Google Patents
Boronsäurehaltige reagenzien und oligonukleotideInfo
- Publication number
- ATE301664T1 ATE301664T1 AT00916555T AT00916555T ATE301664T1 AT E301664 T1 ATE301664 T1 AT E301664T1 AT 00916555 T AT00916555 T AT 00916555T AT 00916555 T AT00916555 T AT 00916555T AT E301664 T1 ATE301664 T1 AT E301664T1
- Authority
- AT
- Austria
- Prior art keywords
- reagents
- boronic acid
- oligonucleotides containing
- containing boronic
- polynucleotides
- Prior art date
Links
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 150000001543 aryl boronic acids Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6596—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having atoms other than oxygen, sulfur, selenium, tellurium, nitrogen or phosphorus as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/272,834 US6013783A (en) | 1999-03-19 | 1999-03-19 | Boronic acid containing oligonucleotides and polynucleotides |
| US09/272,978 US6031117A (en) | 1999-03-19 | 1999-03-19 | Boronic acid containing phosphoramidite reagents |
| PCT/US2000/007370 WO2000056740A1 (en) | 1999-03-19 | 2000-03-17 | Boronic acid containing reagents and oligonucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE301664T1 true ATE301664T1 (de) | 2005-08-15 |
Family
ID=26955773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00916555T ATE301664T1 (de) | 1999-03-19 | 2000-03-17 | Boronsäurehaltige reagenzien und oligonukleotide |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1165569B1 (de) |
| JP (1) | JP3917372B2 (de) |
| KR (1) | KR100541842B1 (de) |
| CN (1) | CN1354752A (de) |
| AT (1) | ATE301664T1 (de) |
| AU (1) | AU778741B2 (de) |
| CA (1) | CA2368101A1 (de) |
| DE (1) | DE60021862D1 (de) |
| EA (1) | EA200100987A1 (de) |
| MX (1) | MXPA01009390A (de) |
| WO (1) | WO2000056740A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012031243A2 (en) | 2010-09-03 | 2012-03-08 | Avi Biopharma, Inc. | dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS |
| KR20140097398A (ko) | 2011-11-18 | 2014-08-06 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | 기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트 |
| WO2013110005A1 (en) * | 2012-01-18 | 2013-07-25 | Wisconsin Alumni Research Foundation | Boronate-mediated delivery of molecules into cells |
| US9732101B2 (en) | 2012-01-18 | 2017-08-15 | Wisconsin Alumni Research Foundation | Bioreversible boronates for delivery of molecules into cells |
| US9920085B2 (en) | 2012-03-20 | 2018-03-20 | Sarepta Therapeutics, Inc. | Boronic acid conjugates of oligonucleotide analogues |
| US11020417B2 (en) | 2015-06-04 | 2021-06-01 | Sarepta Therapeutics, Inc | Methods and compounds for treatment of lymphocyte-related diseases and conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5831046A (en) * | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
| US6013783A (en) * | 1999-03-19 | 2000-01-11 | Prolinx Incorporated | Boronic acid containing oligonucleotides and polynucleotides |
| US6031117A (en) * | 1999-03-19 | 2000-02-29 | Prolinx Incorporated | Boronic acid containing phosphoramidite reagents |
-
2000
- 2000-03-17 CN CN00805176A patent/CN1354752A/zh active Pending
- 2000-03-17 MX MXPA01009390A patent/MXPA01009390A/es active IP Right Grant
- 2000-03-17 DE DE60021862T patent/DE60021862D1/de not_active Expired - Lifetime
- 2000-03-17 EA EA200100987A patent/EA200100987A1/ru unknown
- 2000-03-17 EP EP00916555A patent/EP1165569B1/de not_active Expired - Lifetime
- 2000-03-17 JP JP2000606601A patent/JP3917372B2/ja not_active Expired - Fee Related
- 2000-03-17 AU AU37645/00A patent/AU778741B2/en not_active Ceased
- 2000-03-17 KR KR1020017011946A patent/KR100541842B1/ko not_active Expired - Fee Related
- 2000-03-17 AT AT00916555T patent/ATE301664T1/de not_active IP Right Cessation
- 2000-03-17 CA CA002368101A patent/CA2368101A1/en not_active Abandoned
- 2000-03-17 WO PCT/US2000/007370 patent/WO2000056740A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2368101A1 (en) | 2000-09-28 |
| CN1354752A (zh) | 2002-06-19 |
| EP1165569A1 (de) | 2002-01-02 |
| WO2000056740A1 (en) | 2000-09-28 |
| EA200100987A1 (ru) | 2002-04-25 |
| MXPA01009390A (es) | 2003-06-06 |
| KR20020001786A (ko) | 2002-01-09 |
| AU778741B2 (en) | 2004-12-16 |
| JP2002540113A (ja) | 2002-11-26 |
| KR100541842B1 (ko) | 2006-01-16 |
| AU3764500A (en) | 2000-10-09 |
| JP3917372B2 (ja) | 2007-05-23 |
| DE60021862D1 (de) | 2005-09-15 |
| EP1165569B1 (de) | 2005-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69637256D1 (de) | Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle | |
| DE69503129D1 (de) | Pteridin-nukleotidderivate als fluoreszierende sonden | |
| PT990047E (pt) | Metodos e composicoes para a analise de acidos nucleicos por espectroscopia de massa. | |
| DE60036277D1 (de) | Testgerät zur durchführung von nukleinsäure-amplifikationsreaktionen | |
| ATE318138T1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| AU4941101A (en) | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods | |
| EP1005494A4 (de) | Polyvalente und polyspezifische reagentienmit hoher avidität | |
| CY1106991T1 (el) | Αντιπολλαπλασιαστικη δραση ολιγονουκλεοτιδιων πλουσιων σε g και μεθοδος χρησιμοποιησης αυτων για την προσδεση σε νουκλεολινη | |
| DE10001477B4 (de) | Diskontinuierliches Polykondensationsverfahren und Rührscheibenreaktor hierfür | |
| BR0109062A (pt) | Inibidores de frutose-1,6-bisfosfatase de arila | |
| ATE298623T1 (de) | Chemischer reaktor und verfahren zur katalytischen gasphasenreaktionen | |
| DE69817066D1 (de) | Exothermo Reaktionen und Verfahren dazu | |
| DE69822473D1 (de) | Lipid-polyamid-konjugate und zusammensetzungen zur verabreichung von nucleinsäuremolekülen | |
| DE69928667D1 (de) | Nicht-peptide inhibitoren von vla-4 abhängiger zellbindung für die behandlung von entzündungen, autoimmune krankheiten und atemstörungen | |
| DE60116442D1 (de) | System zur Zuordnung von Schlüsselwörtern zu Dokumenten | |
| DE69609725D1 (de) | Neue polymerträger zur nukleinsäuresynthese | |
| ATE342911T1 (de) | Synthese von nukleosiden und polynukleotiden | |
| DE60009665D1 (de) | Zusammensetzungen zur behandlung von entzündungsreaktionen | |
| ATE263842T1 (de) | Multiplex-sequenzierungsverfahren | |
| DE59809244D1 (de) | Reaktor für chemische Umsetzungen | |
| DE60027045D1 (de) | Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe | |
| DE60021862D1 (de) | Boronsäurehaltige reagenzien und oligonukleotide | |
| ATE518963T1 (de) | Evaneszenz-basierendes multiplex- sequenzierungsverfahren | |
| DE59906395D1 (de) | Vorrichtung zur durchführung von chemischen reaktionen | |
| DE59814359D1 (de) | Mikrostrukturierter biosensor, verwendung des biosensors und verfahren zur immobilisierung von biokatalysatoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |